BioCatalystWatch
VORWorkspace / VOR / OverviewCompany library
Price
Market cap
Next catalystExpected 1H 2027telitacicept — UPSTREAM oMG · Trial initiationCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

telitacicept

BAFF (BLyS) × APRIL

PreINDP1P2P3FilingApproved
Upcoming / outlook

telitacicept

BAFF (BLyS) × APRIL

PreINDP1P2FilingApproved
Upcoming / outlook

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

telitacicept

telitacicept

telitacicept

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

telitacicept

BAFF (BLyS) × APRIL

PreINDP1P2P3FilingApproved
Upcoming / outlook

telitacicept

BAFF (BLyS) × APRIL

PreINDP1P2FilingApproved
Upcoming / outlook

  • Timing and evidence

Other pipelines

telitacicept

BAFF (BLyS) × APRIL

PreINDP1P2P3FilingApproved
telitacicept

BAFF (BLyS) × APRIL

telitacicept

BAFF (BLyS) × APRIL

PreINDP1P2P3FilingApproved
RC298

BAFF × APRIL

Upcoming / outlook

Partner / License out

telitacicept

BAFF (BLyS) × APRIL

PreINDP1P2P3FilingApproved

Approved / commercial

telitacicept

BAFF (BLyS) × APRIL

PreINDP1P2P3FilingApproved
telitacicept

BAFF (BLyS) × APRIL

PreINDP1P2P3FilingApproved

History / paused

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Source and basis

Source and basis

Source and basis

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

VOR PR & News

PR & News

VOR SEC archive